1. Home
  2. ACTU vs PHD Comparison

ACTU vs PHD Comparison

Compare ACTU & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • PHD
  • Stock Information
  • Founded
  • ACTU 2015
  • PHD 2004
  • Country
  • ACTU United States
  • PHD United States
  • Employees
  • ACTU N/A
  • PHD N/A
  • Industry
  • ACTU
  • PHD Investment Managers
  • Sector
  • ACTU
  • PHD Finance
  • Exchange
  • ACTU NYSE
  • PHD Nasdaq
  • Market Cap
  • ACTU 135.0M
  • PHD 120.3M
  • IPO Year
  • ACTU 2024
  • PHD N/A
  • Fundamental
  • Price
  • ACTU $6.55
  • PHD $9.89
  • Analyst Decision
  • ACTU Strong Buy
  • PHD
  • Analyst Count
  • ACTU 1
  • PHD 0
  • Target Price
  • ACTU $20.00
  • PHD N/A
  • AVG Volume (30 Days)
  • ACTU 143.8K
  • PHD 67.7K
  • Earning Date
  • ACTU 05-15-2025
  • PHD 01-01-0001
  • Dividend Yield
  • ACTU N/A
  • PHD 11.43%
  • EPS Growth
  • ACTU N/A
  • PHD N/A
  • EPS
  • ACTU N/A
  • PHD 1.27
  • Revenue
  • ACTU N/A
  • PHD N/A
  • Revenue This Year
  • ACTU N/A
  • PHD N/A
  • Revenue Next Year
  • ACTU N/A
  • PHD N/A
  • P/E Ratio
  • ACTU N/A
  • PHD $7.60
  • Revenue Growth
  • ACTU N/A
  • PHD N/A
  • 52 Week Low
  • ACTU $5.50
  • PHD $8.30
  • 52 Week High
  • ACTU $11.99
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • PHD 69.64
  • Support Level
  • ACTU N/A
  • PHD $9.79
  • Resistance Level
  • ACTU N/A
  • PHD $9.83
  • Average True Range (ATR)
  • ACTU 0.00
  • PHD 0.05
  • MACD
  • ACTU 0.00
  • PHD 0.00
  • Stochastic Oscillator
  • ACTU 0.00
  • PHD 100.00

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.

Share on Social Networks: